AH
LAB icon

Andreas Halvorsen’s Standard BioTools LAB Stock Holding History

Andreas Halvorsen’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.3M Hold
58,651,170
– – 0.14% 75
2026
Q1 		$53.9M Hold
58,651,170
– – 0.15% 71
2025
Q4 		$75.1M Hold
58,651,170
– – 0.2% 70
2025
Q3 		$76.2M Hold
58,651,170
– – 0.2% 68
2025
Q2 		$70.4M Hold
58,651,170
– – 0.2% 72
2025
Q1 		$63.3M Hold
58,651,170
– – 0.2% 71
2024
Q4 		$103M Hold
58,651,170
– – 0.33% 63
2024
Q3 		$113M Hold
58,651,170
– – 0.41% 62
2024
Q2 		$104M Hold
58,651,170
– – 0.4% 55
2024
Q1 		$159M Buy
+58,651,170
New +$142M 0.59% 44

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Andreas Halvorsen's LAB Position: Q2 2026 in Review

Andreas Halvorsen held its Standard BioTools (LAB) position steady in Q2 2026 at 58,651,170 shares worth $48.3M. The position accounts for 0.14% of the portfolio, ranked #75.

Andreas Halvorsen first reported a position in LAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $159M in Q1 2024. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Andreas Halvorsen held 58,651,170 shares of Standard BioTools worth $48.3M as of Q2 2026.
  • Andreas Halvorsen left its Standard BioTools share count unchanged in Q2 2026.
  • Standard BioTools made up 0.14% of Andreas Halvorsen's portfolio in Q2 2026, its #75 holding.
  • Andreas Halvorsen first reported a position in Standard BioTools in Q1 2024 and has held it in 10 quarters since.
  • Andreas Halvorsen's Standard BioTools position peaked at $159M in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Viking Global Investors's 13F filing for Q2 2026, filed 14 Aug 2026.